Bioventus plans revolver and term loan A paydown with notes proceeds

By Sara Rosenberg

New York, April 26 – Bioventus LLC intends to repay a portion of its revolving credit facility and term loan A borrowings using proceeds from a $415 million senior notes offering, according to a market source.

The notes offering will also be used to acquire the remaining shares of CartiHeal Ltd. for about $265 million and to pay related fees and expenses.

Bioventus is a Durham, N.C.-based medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.